Edit Content
Bizwit-Logo-Final

Bizwit Research & Consulting LLP is a global provider of business intelligence & consulting services. We have a strong primary base of key industry leaders along with the chain of industry analysts to analyze the market trends and its future impact in order to estimates and forecast different business segments and markets. 

Global Epilepsy Drugs Market to reach USD XXXX billion by the end of 2030.

Global Epilepsy Drugs Market Size study & Forecast, by Drugs (First Generation Anti-epileptics, Second Generation Anti-epileptics, Third Generation Anti-epileptics), by Distribution Channel (Hospital Pharmacy, Pharmacy Stores, Others) and Regional Analysis, 2023-2030

Product Code: HLSDT-76942035
Publish Date: 1-07-2023
Page: 200

Global Epilepsy Drugs Market is valued at approximately USD XXX billion in 2022 and is anticipated to grow with a healthy growth rate of more than XXX% over the forecast period 2023-2030. Epilepsy is a neurological disorder characterized by recurrent seizures, and there are many drugs available to treat this condition. The choice of medication depends on the type of epilepsy, the age of the patient, and other factors such as the patient’s overall health and the presence of other medical conditions. However, the market for epileptic drugs is growing as a result of an increase in the number of persons who suffer from epilepsy. A widespread neurological illness, epilepsy is a major market-driving factor due to the rise in prevalence of the condition globally. Additionally, epilepsy is affecting more people due to factors like population growth, ageing populations, and improved diagnosis, all of which contribute to the market’s expansion. For instance, epilepsy incidence rates rise with age and are highest in people over the age of 75, according to a report released by UpToDate Inc. in August 2021. As a result, the demand for epilepsy drugs is driven by the rising prevalence of epilepsy among the senior population, which is supporting market growth.

Moreover, the rise in new drug approvals by the government authority is anticipated to create a lucrative demand for the market during forecast period. For instance, In March 2022, The United States Food and Drug Administration granted Lupin’s abbreviated new drug application (ANDA) for Vigabatrin approval. It is an anti-epileptic drug that will be sold as a 500 mg oral solution USP. Also, In March 2022, The US Food and Drug Administration approved the drug Ztalmy from Marinus Pharmaceuticals to treat seizures in people with CDKL5 deficiency, a genetic form of epilepsy. As a result, the rising drug approvals are anticipated to support the market growth during projected period. Additionally, rising research and development activities related to epilepsy drugs is anticipated to create a lucrative opportunity for the market during forecast period. However, the side effects associated with the drugs stifles market growth throughout the forecast period of 2023-2030.

The key regions considered for the Global Epilepsy Drugs Market study include Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 owing to the presence of key market players, rising burden of epilepsy coupled with the strategic initiatives, awareness campaigns, and development of new products by the market players in the region. Asia Pacific is expected to grow significantly during the forecast period, owing to factors such as rising geriatric population, growing prevalence of epilepsy, and the presence of high unmet medical needs in emerging economies of India and China.

Major market players included in this report are:
Novartis AG
GlaxoSmithKline plc
Sanofi S.Aa
UCB S.A.
Abbott Laboratories
Bausch Health Companies, Inc
Viatris Inc.
Johnson & Johnson
Sumitomo Pharma Co., Ltd
H. Lundbeck A/S

Recent Developments in the Market:
Ø In Nov. 2020, According to UCB S.A., a global pharmaceutical company, the U.S. Food and Drug Administration (FDA) has approved both VIMPAT (lacosamide) CV and VIMPAT injection for intravenous use in children four years of age and older for the treatment of primary generalised tonic-clonic seizures (PGTCS).
Global Epilepsy Drugs Market Report Scope:
ü Historical Data – 2020 – 2021
ü Base Year for Estimation – 2022
ü Forecast period – 2023-2030
ü Report Coverage – Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
ü Segments Covered – Drugs, Distribution Channel, Region
ü Regional Scope – North America; Europe; Asia Pacific; Latin America; Middle East & Africa
ü Customization Scope – Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Drugs:
First Generation Anti-epileptics
Second Generation Anti-epileptics
Third Generation Anti-epileptics

By Distribution Channel:
Hospital Pharmacy
Pharmacy Stores
Others

By Region:

North America
U.S.
Canada

Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC

Latin America
Brazil
Mexico

Middle East & Africa
Saudi Arabia
South Africa
Rest of Middle East & Africa

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
1.2.1. Epilepsy Drugs Market, by Region, 2020-2030 (USD Billion)
1.2.2. Epilepsy Drugs Market, by Drugs, 2020-2030 (USD Billion)
1.2.3. Epilepsy Drugs Market, by Distribution Channel, 2020-2030 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Epilepsy Drugs Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Industry Evolution
2.2.2. Scope of the Study
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Epilepsy Drugs Market Dynamics
3.1. Epilepsy Drugs Market Impact Analysis (2020-2030)
3.1.1. Market Drivers
3.1.1.1. Increase in the New Drug Approvals over the Past Few Years

3.1.1.2. Growing Prevalence of Epilepsy
3.1.2. Market Challenges
3.1.2.1. Side Effects Associated with the Drugs
3.1.3. Market Opportunities
3.1.3.1. Rising Research and Development Activities Related to Epilepsy Drugs
Chapter 4. Global Epilepsy Drugs Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Porter’s 5 Force Impact Analysis
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.3.5. Environmental
4.3.6. Legal
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. COVID-19 Impact Analysis
4.7. Disruptive Trends
4.8. Industry Expert Perspective
4.9. Analyst Recommendation & Conclusion
Chapter 5. Global Epilepsy Drugs Market, by Drugs
5.1. Market Snapshot
5.2. Global Epilepsy Drugs Market by Drugs, Performance – Potential Analysis
5.3. Global Epilepsy Drugs Market Estimates & Forecasts by Drugs 2020-2030 (USD Billion)
5.4. Epilepsy Drugs Market, Sub Segment Analysis
5.4.1. First Generation Anti-epileptics
5.4.2. Second Generation Anti-epileptics
5.4.3. Third Generation Anti-epileptics
Chapter 6. Global Epilepsy Drugs Market, by Distribution Channel
6.1. Market Snapshot
6.2. Global Epilepsy Drugs Market by Distribution Channel, Performance – Potential Analysis
6.3. Global Epilepsy Drugs Market Estimates & Forecasts by Distribution Channel 2020-2030 (USD Billion)
6.4. Epilepsy Drugs Market, Sub Segment Analysis
6.4.1. Hospital Pharmacy
6.4.2. Pharmacy Stores
6.4.3. Others
Chapter 7. Global Epilepsy Drugs Market, Regional Analysis
7.1. Top Leading Countries
7.2. Top Emerging Countries
7.3. Epilepsy Drugs Market, Regional Market Snapshot
7.4. North America Epilepsy Drugs Market
7.4.1. U.S. Epilepsy Drugs Market
7.4.1.1. Drugs breakdown estimates & forecasts, 2020-2030
7.4.1.2. Distribution Channel breakdown estimates & forecasts, 2020-2030
7.4.2. Canada Epilepsy Drugs Market
7.5. Europe Epilepsy Drugs Market Snapshot
7.5.1. U.K. Epilepsy Drugs Market
7.5.2. Germany Epilepsy Drugs Market
7.5.3. France Epilepsy Drugs Market
7.5.4. Spain Epilepsy Drugs Market
7.5.5. Italy Epilepsy Drugs Market
7.5.6. Rest of Europe Epilepsy Drugs Market
7.6. Asia-Pacific Epilepsy Drugs Market Snapshot
7.6.1. China Epilepsy Drugs Market
7.6.2. India Epilepsy Drugs Market
7.6.3. Japan Epilepsy Drugs Market
7.6.4. Australia Epilepsy Drugs Market
7.6.5. South Korea Epilepsy Drugs Market
7.6.6. Rest of Asia Pacific Epilepsy Drugs Market
7.7. Latin America Epilepsy Drugs Market Snapshot
7.7.1. Brazil Epilepsy Drugs Market
7.7.2. Mexico Epilepsy Drugs Market
7.8. Middle East & Africa Epilepsy Drugs Market
7.8.1. Saudi Arabia Epilepsy Drugs Market
7.8.2. South Africa Epilepsy Drugs Market
7.8.3. Rest of Middle East & Africa Epilepsy Drugs Market

Chapter 8. Competitive Intelligence
8.1. Key Company SWOT Analysis
8.1.1. Company 1
8.1.2. Company 2
8.1.3. Company 3
8.2. Top Market Strategies
8.3. Company Profiles
8.3.1. Novartis AG
8.3.1.1. Key Information
8.3.1.2. Overview
8.3.1.3. Financial (Subject to Data Availability)
8.3.1.4. Product Summary
8.3.1.5. Recent Developments
8.3.2. GlaxoSmithKline plc
8.3.3. Sanofi S.Aa
8.3.4. UCB S.A.
8.3.5. Abbott Laboratories
8.3.6. Bausch Health Companies, Inc
8.3.7. Viatris Inc.
8.3.8. Johnson & Johnson
8.3.9. Sumitomo Pharma Co., Ltd
8.3.10. H. Lundbeck A/S.
Chapter 9. Research Process
9.1. Research Process
9.1.1. Data Mining
9.1.2. Analysis
9.1.3. Market Estimation
9.1.4. Validation
9.1.5. Publishing
9.2. Research Attributes
9.3. Research Assumption

At Bizwit Research and Consultancy, we employ a thorough and iterative research methodology with the goal of minimizing discrepancies, ensuring the provision of highly accurate estimates and predictions over the forecast period. Our approach involves a combination of bottom-up and top-down strategies to effectively segment and estimate quantitative aspects of the market, utilizing our proprietary data & AI tools. Our Proprietary Tools allow us for the creation of customized models specific to the research objectives. This enables us to develop tailored statistical models and forecasting algorithms to estimate market trends, future growth, or consumer behavior. The customization enhances the accuracy and relevance of the research findings.
We are dedicated to clearly communicating the purpose and objectives of each research project in the final deliverables. Our process begins by identifying the specific problem or challenge our client wishes to address, and from there, we establish precise research questions that need to be answered. To gain a comprehensive understanding of the subject matter and identify the most relevant trends and best practices, we conduct an extensive review of existing literature, industry reports, case studies, and pertinent academic research.
Critical elements of methodology employed for all our studies include:
Data Collection:
To determine the appropriate methods of data collection based on the research objectives, we consider both primary and secondary sources. Primary data collection involves gathering information directly from various industry experts in core and related fields, original equipment manufacturers (OEMs), vendors, suppliers, technology developers, alliances, and organizations. These sources encompass all segments of the value chain within the specific industry. Through in-depth interviews, we engage with key industry participants, subject-matter experts, C-level executives of major market players, industry consultants, and other relevant experts. This allows us to obtain and validate critical qualitative and quantitative information while evaluating market prospects. AI and Big Data are instrumental in our primary research, providing us with powerful tools to collect, analyze, and derive insights from data efficiently. These technologies contribute to the advancement of research methodologies, enabling us to make data-driven decisions and uncover valuable findings.
In addition to primary sources, we extensively utilize secondary sources to enhance our research. These include directories, databases, journals focusing on related industries, company newsletters, and information portals such as Bloomberg, D&B Hoovers, and Factiva. These secondary sources enable us to identify and gather valuable information for our comprehensive, technical, market-oriented, and commercial study of the market. Additionally, we utilize AI algorithms to automate the collection of vast amounts of data from various sources such as surveys, social media platforms, online transactions, and web scraping. And employ Big Data technologies for storage and processing of large datasets, ensuring that no valuable information is missed during the data collection process.
Data Analysis:
Our team of experts carefully examine the gathered data using suitable statistical techniques and qualitative analysis methods. For quantitative analysis, we employ descriptive statistics, regression analysis, and other advanced statistical methods, depending on the characteristics of the data. This analysis may also incorporate the utilization of AI tools and big data analysis techniques to extract meaningful insights.
To ensure the accuracy and reliability of our findings, we extensively leverage data science techniques, which help us minimize discrepancies and uncertainties in our analysis. We employ Data Science to clean and preprocess the data, ensuring its quality and reliability. This involves handling missing data, removing outliers, standardizing variables, and transforming data into suitable formats for analysis. The application of data science techniques enhances our accuracy, efficiency, and depth of analysis, enabling us to stay competitive in dynamic market environments.
Market Size Estimation:
Our proprietary data tools play a crucial role in deriving our market estimates and forecasts. Each study involves the creation of a unique and customized model. The model incorporates the gathered information on market dynamics, technology landscape, application development, and pricing trends. AI techniques, such as machine learning and deep learning, aid us to analyze patterns within the data to identify correlations, trends, and relationships. By recognizing patterns in consumer behavior, purchasing habits, or market dynamics, our AI algorithms aid us in more precise estimations of market size. These factors are simultaneously analyzed within the model, allowing for a comprehensive assessment. To quantify their impact over the forecast period, correlation, regression, and time series analysis are employed.
To estimate and validate the market size, we employ both top-down and bottom-up approaches. The preference is given to a bottom-up approach, where key regional markets are analyzed as separate entities. This data is then integrated to obtain global estimates. This approach is crucial as it provides a deep understanding of the industry and helps minimize errors.
In our forecasting process, we consider various parameters such as economic tools, technological analysis, industry experience, and domain expertise. By taking all these factors into account, we strive to produce accurate and reliable market forecasts. When forecasting, we take into consideration several parameters, which include:
Market driving trends and favorable economic conditions
Restraints and challenges that are expected to be encountered during the forecast period.
Anticipated opportunities for growth and development
Technological advancements and projected developments in the market
Consumer spending trends and dynamics
Shifts in consumer preferences and behaviors.
The current state of raw materials and trends in supply versus pricing
Regulatory landscape and expected changes or developments.
The existing capacity in the market and any expected additions or expansions up to the end of the forecast period.
To assess the market impact of these parameters, we assign weights to each one and utilize weighted average analysis. This process allows us to quantify their influence on the market and derive an expected growth rate for the forecasted period. By considering these various factors and applying a weighted analysis approach, we strive to provide accurate and reliable market forecasts.
Insight Generation & Report Presentation:
After conducting the research, our experts analyze the findings in relation to the research objectives and the specific needs of the client. They generate valuable insights and recommendations that directly address the client’s business challenges. These insights are carefully connected to the research findings to provide a comprehensive understanding.
Next, we create a well-structured research report that effectively communicates the research findings, insights, and recommendations to the client. To enhance clarity and comprehension, we utilize visual aids such as charts, graphs, and tables. These visual elements are employed to present the data in an engaging and easily understandable format, ensuring that the information is accessible and visually appealing to the client. Our aim is to deliver a clear and concise report that conveys the research findings effectively and provides actionable recommendations to meet the client’s specific needs.

Need Assistance

Contact Person -
Krishant Mennon
Call us @
+ 91 99931 15879
Email: sales@bizwitresearch.com

Checkout

Why Choose Us?

Quality over Quantity

Backed by 60+ paid data sources our reports deliver crisp insights with no compromise quality.

Analyst Support

24x7 Chat Support plus
free analyst hours with every purchase

Flawless Methodology

Our 360-degree approach of market study, our research methods leave stones unturned.

Enquiry Now